Legal & General Group »

Celldex Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 52k 39.66
2023-09-30 $1.1M 41k 27.52
2023-06-30 $1.3M 37k 33.93
2023-03-31 $677k 19k 35.98
2022-12-31 $767k 17k 44.57
2022-09-30 $474k 17k 28.13
2022-06-30 $435k 16k 26.96
2022-03-31 $572k 17k 34.07
2021-12-31 $638k 17k 38.60
2021-09-30 $920k 17k 54.85
2021-06-30 $206k 6.1k 33.76
2021-03-31 $35k 1.7k 20.58
2020-12-31 $30k 1.7k 17.64